HuagongsheHuagongshe Chemistry Print Report · For research reference only
4-Bromoisatin → 5-Bromoquinazoline-2,4(1H,3H)-dione
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 4-Bromoisatin | HCID 4500012 | — |
| Reactant | NaNCO | HCID 11051568 | — |
| Reactant | HCID 67055862 | HCID 67055862 | — |
| Product | 5-Bromoquinazoline-2,4(1H,3H)-dione | HCID 19604232 | — |
Reaction Steps
Compounds of formula I may be synthesized according to Scheme 1. Commercially available 4-bromoindoline-2,3-dione may be hydrolyzed to 2-amino-6-bromobenzamide followed by condensation with sodium isocyanate to form 5-bromoquinazoline-2,4(1H,3H)-dione. The protocols include, but are not limited to, palladium mediated cross coupling between 5-bromoquinazoline-2,4(1H,3H)-dione and the aryl boronic acid or ester to form the intermediate 5-substituted quinazoline-2,4(1H, 3H)-dione. Conversion to the corresponding dichloro quinazoline and sequential displacement at the 4-position followed by transition metal mediated cross coupling or displacement of the C2 chloride forms compounds I as described.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08575184B2 |
| Source dataset | uspto-grants-2013_11 |
| ORD ID | ord-3f25f49a6c034ec8a67f805d044e903f |
| Source note | uspto-grants-2013_11 |